Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 1168
Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
     

Table of Contents
CASE REPORT
Year : 2011  |  Volume : 5  |  Issue : 1  |  Page : 24-27

Nasal rhinosporidiosis with oropharyngeal extension


1 Department of ENT, Dr. Pinnamneni Siddhartha Institute of Medical Sciences, Chinna Outpalli, Krishna District, India
2 Department of Oral Pathology, St. Joseph Dental College and Hospital, Duggirala, Eluru, Andhra Pradesh, India

Date of Web Publication24-Aug-2011

Correspondence Address:
A Anuradha
D. No. 10/200, Anuradha ENT Hospital, Eluru Road, Gudivada, Krishna 521 301, Andhra Pradesh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0331-3131.84226

Rights and Permissions
   Abstract 

Rhinosporidiosis is a chronic infestation by the fungus Rhinosporidium seeberi, which predominantly affects the mucus membranes of the nose and nasopharynx. We report a case of rhinosporidoisis with presentation as a mass extending up to the oropharynx. Functional endoscopic sinus surgery was performed.

Keywords: Endospores, mass, oropharynx, rhinosporidiosis


How to cite this article:
Babu S, Anuradha A, Chandra S, Kashyap B. Nasal rhinosporidiosis with oropharyngeal extension. Ann Nigerian Med 2011;5:24-7

How to cite this URL:
Babu S, Anuradha A, Chandra S, Kashyap B. Nasal rhinosporidiosis with oropharyngeal extension. Ann Nigerian Med [serial online] 2011 [cited 2019 Sep 23];5:24-7. Available from: http://www.anmjournal.com/text.asp?2011/5/1/24/84226


   Introduction Top


Rhinosporidium is a cosmopolitan disease of man and domestic animals endemic in India and Sri Lanka and is hyperendemic in southern districts of Tamil Nadu. It usually presents as a polypoidal growth in nasal cavity that involves the anterior part of nasal septum and nasal vestibule. This case has been presented for its occurrence in a nonendemic, nondiabetic, non-HIV patient as a huge mass with oropharyngeal extension.


   Case Report Top


A 42-year-old male from Orissa, professionally a farmer, came to the outpatient department with a complaint of foreign body sensation in the throat present since 4 years and nasal obstruction for the past 6 years. He was also suffering from recurrent episodes of headache and dysphagia for past 6 months. There was occasional history of otalgia and epistaxis. His medical history was noncontributory. Anterior rhinoscopy showed bilateral pinkish polypoidal mass filling both the nasal cavities [Figure 1]. The nasal mucosa was swollen, hyperemic, and covered with copious viscid secretion. The erythematous polypoidal mass of 5 Χ 4 cm 2 size was seen extending through the nasopharynx and hanging into the oropharynx up to the level of the posterior one-third of the tongue along the posterior pharyngeal wall [Figure 2]. It was nonpulsating or expansile and did not bleed on touch. Lymphnodal involvement was absent. CT scan revealed haziness of the maxillary sinus with bilateral hyper dense mass filling the nasal cavities with oropharyngeal extension [Figure 3] and [Figure 4]. A differential diagnosis of infected polyp, inverted ductal papilloma, fungal proliferation was given. Functional endoscopic sinus surgery was performed and the nasopharyngeal mass was excised and the tissue was sent for histopathological examination [Figure 5].
Figure 1: Bilateral pinkish mass fi lling the nasal cavities prominent on the left

Click here to view
Figure 2: Reddish pink irregular mass in the oropharynx

Click here to view
Figure 3: CT picture shows bilateral nasal mass with bilateral maxillary sinus haziness

Click here to view
Figure 4: CT picture shows oropharyngeal extension of the mass

Click here to view
Figure 5: Excised mass

Click here to view


The specimen on gross examination was polypoidal, soft, friable, and pink in color with white spots on the surface. Histopathological examination of tissue sections stained with hematoxylin and eosin and periodic acid-Schiff (PAS) stain showed a surface stratified squamous epithelium. The subepithelium showed many globular cysts. Each of these cysts represented a thick-walled sporangium containing numerous "daughter spores" in different stages of development. The fibrous connective stroma showed fibroblasts and an inflammatory infiltrate consisting of polymorphs and eosinophils [Figure 6] and [Figure 7]. These changes were characteristic of rhinosporidiosis.
Figure 6: Hematoxylin and eosin tissue sections lined by stratifi ed squamous epithelium and subepithelial thick-walled globular cysts containing numerous daughter spores in different stages of development

Click here to view
Figure 7: Periodic acid-Schiff stained sections demonstrating the sporangia in a fibromyxoid stroma containing polymorphs and eosinophils

Click here to view



   Discussion Top


The first known case of rhinosporidiosis was identified in 1892 by Malbran of Buenos Aires. Seeber published the first detailed account of rhinosporidiosis in 1900. In 1923, Ashworth described the fungus' life cycle, and in 1964, Karunaratne published a complete review of rhinosporidiosis in a man. Other than India and Sri Lanka where this disease is endemic, it has been recognized in many other parts of the world, such as South America, United states, England, Egypt, and South Africa.

Rhinosporidiosis predominantly affects the mucous membranes of the nose and nasopharynx; it also occasionally involves the lips, palate, uvula, maxillary antrum, conjunctiva, lacrimal sac, epiglottis, larynx, trachea, bronchus, ear, scalp, skin, penis, vulva, and vagina. Water and soil are believed to be the reservoir of infection, given the increased incidence of disease found in sandworkers, paddy cultivators, and people bathing in stagnant muddy waters. Mode of transmission is through water or dust, from which the endospores penetrate the nasal mucosa, mature into sporangium within the submucosal compartment and after maturation burst with release of sporangia into surrounding tissue. Clinically, the lesion presents as a soft, polypoid, mass sometimes pedunculated in the nose, the eye and its adnexa, conjunctiva, or the urethra. Larynx, trachea, skin, and lung are less frequently involved. Osteolytic bone infiltration is another clinical presentation. Histologically, the infected tissue reveals granulomatous reaction, pseudocystic abscesses, and fibrosis around the causative organism. [1],[2],[3]

The taxonomy of the causative organism is unclear. It shows morphological features resembling those of fungi and protozoa. Although most microbiologists had initially considered it a fungus as fungal stains such as methanamine silver and PAS could stain the wall of the organism but culture of R. seeberi had been unsuccessful in all artificial media; however, it could be maintained through its life cycle in tissue cultures. Recently, Ahluwalia et al. hypothesized that the causative organism was not a fungus but a prokaryotic cyanobacterium Microcystis aeruginosa, based on the findings that this organism was isolated from both the clinical specimens of patients and the pond water samples where they bathed. [4],[5],[6] Herr et al. however, through analysis of the 18S small subunit ribosomal DNA groups, concluded that R. seeberi was related to a group of fish parasites referred to as the DRIP clade (Dermatocystidium, rosette agent, icthyophonus and psorospermium). [7] The biological agent has a mature stage that consists of large, thick-walled spherical structures (called sporangia) containing smaller "daughter cells" (called "sporangiospores"), and it can be visualized with fungal stains as Gomori methenamine silver (GMS) and PAS, as well as with standard hematoxylin and eosin (HandE) staining.

Surgical excision is the mainstay of treatment. It has been advocated that a wide surgical margin is necessary to reduce the risk of recurrence, though this may be associated with significant morbidity such as hemorrhage and nasal septal perforation. Because of this, limited surgical excision with cautery of the base of the lesion has been attempted, and to further reduce the risk of recurrence, various adjuvant medical therapies, including anti-fungals such as Griseofulvin and Amphotericin B, have been tried without much success. The only drug appearing to have clinical promise is Dapsone. [8],[9],[10]


   Conclusion Top


Rhinosporidiosis is a condition which both clinicians and laboratory personnel should keep in mind particularly when managing masses in the nasal cavity in patients from endemic places.

 
   References Top

1.Loh KS, Chong SM, Pang YT, Soh K. Rhinosporidiosis: Differential diagnosis of a large nasal mass. Otolaryngol Head Neck Surg 2001;124:121-2.  Back to cited text no. 1
[PUBMED]  [FULLTEXT]  
2.Arseculeratne SN. Microcystis aeruginosa as the causative organism of rhinosporidiosis. Mycopathologia 2000;151:3-4.   Back to cited text no. 2
    
3.Fredricks DN, Jolley JA, Lepp PW, Kosek JC, Relman DA. Rhinosporidium seeberi: A human pathogen from a novel group of aquatic protistan parasites. Emerg Infect Dis 2000;6:273-82.   Back to cited text no. 3
[PUBMED]  [FULLTEXT]  
4.Ahluwalia KB. Culture of the organism that causes rhinosporidiosis. J Laryngol Otol 1999;113:523-8.  Back to cited text no. 4
[PUBMED]    
5.Ahluwalia KB, Maheshwari N, Deka RC. Rhinosporidiosis: A study that resolves etiologic controversies. Am J Rhinol 1997;11:479-83.  Back to cited text no. 5
[PUBMED]  [FULLTEXT]  
6.Ahluwalia KB. New interpretations in rhinosporidiosis, enigmatic disease of the last nine decades. J Submicrosc Cytol Pathol 1992;24:109-14.   Back to cited text no. 6
[PUBMED]    
7.Herr RA, Ajello L, Taylor JW, Arseculeratne SN, Mendoza L. Phylogenetic analysis of Rhinosporidium seeberi's 18S small subunit ribosomal DNA groups this pathogen among members of the protoctistan Mesomycetozoa clade. J Clin Microbiol 1999;37:2750-4.   Back to cited text no. 7
[PUBMED]  [FULLTEXT]  
8.Nair KK. Clinical trial of diaminodiphenylsulfone (DDS) in nasal and nasopharyngeal rhinsporidiosis. Laryngoscope 1979;89:291-5.  Back to cited text no. 8
[PUBMED]  [FULLTEXT]  
9.Job A, Venkateswaran S, Mathan M, Krishnaswami H, Raman R. Medical therapy of rhinosporidiosis with dapsone. J Laryngol Otol 1993;107:809-12.  Back to cited text no. 9
[PUBMED]    
10.Venkateswaran S, Date A, Job A, Mathan M. Light and electron microscopic findings in rhinosporidiosis after dapsone therapy. Trop Med Int Health 1997;2:1128-32.  Back to cited text no. 10
[PUBMED]    


    Figures

  [Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6], [Figure 7]



 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Abstract
   Introduction
   Case Report
   Discussion
   Conclusion
    References
    Article Figures

 Article Access Statistics
    Viewed6368    
    Printed179    
    Emailed0    
    PDF Downloaded357    
    Comments [Add]    

Recommend this journal